GlassScriptPhysician profile
Kerry A Neises
NPI 1689671372
$11,055.95
in general payments reported to CMS, 2019-2025
52 companies · $1,700 in 2025
The $1,700 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,446 · 2020: $1,271 · 2021: $1,764 · 2022: $1,637 · 2023: $1,673 · 2024: $1,565 · 2025: $1,700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,938.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,222.16 | 2019-2025 | Repatha, Prolia, Evenity |
| Pfizer INC. | $1,197.46 | 2019-2025 | |
| Abbvie INC. | $962.77 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $804.98 | 2019-2025 | Jardiance, Ofev |
| Novo Nordisk INC | $795.72 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $524.46 | 2019-2025 | Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $459.41 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbott Laboratories | $415.66 | 2019-2025 | Freestyle Libre 3 |
| Otsuka America Pharmaceutical, INC. | $385.71 | 2021-2025 | Rexulti |
| Sanofi-Aventis U.S. LLC | $381.10 | 2019-2023 | |
| Amarin Pharma, INC. | $361.96 | 2019-2021 | |
| Lilly USA, LLC | $313.34 | 2019-2025 | Mounjaro, Zepbound |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $304.86 | 2019-2025 | Xifaxan, Trulance |
| Bayer Healthcare Pharmaceuticals INC. | $281.62 | 2021-2025 | |
| Dexcom, INC. | $250.57 | 2022-2025 | Dexcom G6 Transmitter |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $242.20 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $201.83 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Esperion Therapeutics, INC. | $163.45 | 2020-2021 | |
| Astellas Pharma US INC | $153.41 | 2019-2024 | Veozah, Myrbetriq |
| Janssen Pharmaceuticals, INC | $150.25 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $126.29 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $123.56 | 2023-2025 | Gemtesa |
| Biohaven Pharmaceutical Holding Company LTD. | $108.58 | 2022 | |
| Medtronic, INC. | $100.76 | 2022-2025 | Inceptiv, Minimed 780g, Intellis Adaptivestim |
| Sunovion Pharmaceuticals INC. | $94.36 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $93.95 | 2022-2025 | Gvoke Hypopen |
| Phathom Pharmaceuticals, INC. | $70.12 | 2024-2025 | Voquezna |
| Allergan, INC. | $65.49 | 2019-2020 | |
| Radius Health, INC. | $46.09 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.85 | 2022 | |
| Shield Therapeutics INC | $43.28 | 2023-2024 | Accrufer |
| Indivior INC. | $42.62 | 2024-2025 | Sublocade |
| Daiichi Sankyo INC. | $41.02 | 2021-2023 | Injectafer |
| E.R. Squibb & Sons, L.L.C. | $36.60 | 2020-2021 | |
| Horizon Therapeutics Plc | $36.53 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $35.46 | 2025 | Caplyta |
| Inspire Medical Systems, INC. | $33.65 | 2025 | Inspire |
| Boston Scientific Corporation | $33.24 | 2025 | Watchman Access System |
| Biogen, INC. | $32.54 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $32.36 | 2020-2021 | |
| Sanofi Pasteur INC. | $29.11 | 2020-2022 | |
| Exact Sciences Corporation | $27.99 | 2023-2024 | Cologuard Collection Kit |
| Edwards Lifesciences Corporation | $27.42 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Novartis Pharmaceuticals Corporation | $26.24 | 2021-2023 | |
| Lundbeck LLC | $20.79 | 2025 | Rexulti |
| Axsome Therapeutics, INC. | $20.30 | 2025 | Auvelity |
| Seqirus USA INC | $17.32 | 2025 | Fluad, Flucelvax |
| Currax Pharmaceuticals LLC | $15.97 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $15.31 | 2020 | |
| Ethicon US, LLC | $14.53 | 2021 | |
| Smith+Nephew, INC. | $13.64 | 2022 | |
| Melinta Therapeutics, LLC | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Neises listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.